American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study

Lead: Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study

Tuesday 16th July 2024

Explore the link between benzodiazepine use and dementia risk, heavy cannabis use, opioid effects, alcohol's impact on sleep, and more in this episode.
5 minutes
Informative
Educational
Eye-opening
Engaging
Supportive

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Benzodiazepines and Dementia: What the Latest Study Reveals

Episode Overview

  • No general link between benzodiazepine use and dementia risk found.
  • Higher doses of benzodiazepines as anxiolytics linked to increased dementia risk.
  • Heavy cannabis use associated with higher cardiovascular disease mortality in women.
  • Moderate alcohol consumption reduces oxygen levels during sleep on flights.
  • Calls for better medical education on cannabis programmes.
No general link was found between benzodiazepine use and dementia risk, but higher doses used as anxiolytics did show an increased risk
Ever wondered if benzodiazepines could impact your long-term brain health? This episode dives into a population-based study examining the link between benzodiazepine use and dementia risk. Using data from the Rotterdam study, researchers compared benzodiazepine use over 15 years with dementia screenings conducted up to 2020. The findings? No general link between benzodiazepine use and dementia, but higher doses used as anxiolytics did show an increased risk. Intrigued yet? That's just the tip of the iceberg.
The episode also covers heavy cannabis use and its link to cardiovascular disease in women, a new angle on opioid-induced brain changes, and the effects of moderate alcohol consumption on oxygen levels during sleep on long-haul flights. Plus, you'll hear about the confusing role of medical providers in cannabis programmes and why the tobacco industry should stay out of medical education.
Whether you're a healthcare professional or someone curious about addiction medicine, this episode is packed with valuable insights and research findings that could change the way you think about substance use and its long-term effects.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.